Antimicrobial susceptibility pattern and prevalence of extended spectrum β-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi

Journal of Communicable Diseases

Volumn 36, Issue 1, 2004, Pages 17-26

  Grover, S S ^a   Sharma, Meenakshi ^b   Pasha, S T ^a   Singh, Gajendera ^c   Lal, Shiv ^a  

^a NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^c GURU NANAK DEV UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOSYNTHESIS; DRUG EFFECT; ENTEROBACTER INFECTION; ENZYMOLOGY; HOSPITAL; HUMAN; INDIA; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PREVALENCE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; HOSPITALS; HUMANS; INDIA; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PREVALENCE;

EID: 27944447665     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Podschun R and Ulfmann U. Klebsiella spp. as nosocomial pathogens epidemiology, taxonomy, typing methods and pathogencity factors. Clin Microbiol Rev 1998; 11: 589-603.
2. Weller TMA, Mackenziae FM and Forbes KJ. Molecular epidemiology of a large outbreak of multi-resistant. Klebsiella pneumonia. J Med Microbiol 1997; 46: 921-926.
3. Babini G and Livermore DM. Antimicrobial resistance amongst Klebsiella spp. from intensive care units in southern and Western Europe in 1997-1998. J Antimicrob Chemother 2000; 45: 183-189.
4. Ko WC, Paterson DL, Sagnimeni AJ and et al. Community-Acquire Klebsiella Pneumoniae Bacteremia: Global Differences in Clinical patterns. Emerg Infect Dis 2002; 8: 160-175.
5. Abigail S, Mathai E, Jasdasan MV and John TJ. Ceftazidine resistance among Klebsiella pneumoniae in South India Indian J Med Res 1995; 102: 53-55.
6. Peter JB. Antimicrobial resistance in India and United States. Clin Infect Dis 1996; 23: 1315-16.
7. Livermore DM, Winstanky TG and Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob chemother 2000; 48. Supp. 51: 87-102.
8. Medieiros AA. Evolution and dissemination of β-lactamases accelerated by generation of β-lactam antibiotics Clin Iinfect Dis 1997: 24 (Supp) II S 19-45.
9. Forbes BA. Enterobacteriaceae. Baily and Scott's Diagnostic Microbiology, Baltimore, Mosby, 1998: 509-526.
10. th ed. Approved standard M2-A7. NCCLS, Wayne, Pa.2000.
11. Steward CD, Rasheed JK, Susannah KU, Biddle JW, Raney PM, Anderson GJ, et al. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards Extended spectrum β-lactamases detection methods. J Clin Microbial 2001; 39: 2864-2872.
12. Livermore DM. β-lactamases in laboratory and clinical resistance. Clin Microbiol Review, 1995; 8: 557-584.
13. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology and detection of important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.
14. Sabate M, Miro E, Navarro F, Verges C, Aliaga R, Mirelis B, and Prats G. β-lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. Clinical isolates collected between 1994 and 1996, in Barcelona (Spain). J Antimicrob Chemother 2002; 49: 980-997.
15. Nukaga M, Kayako A, Hujer AM, Bonomo RA and Knox JR. Ultra high resolution structure of a class A β-lactamase: on the mechanism and specificity of the extended-spectrum SHV-2 enzyme. J Mol Biol 2003; 328: 289-301.
16. Sanz MA, Lopez J, Lahuerta JJ and et al. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in hematology patients with febrile neutropenia: results of an open, randomized, multi-centre trial. J Antimicrob Chemother 2002; 50: 79-88
17. Jones RN. Resistance patterns among nosocomial pathogens. Chest 2001; 119: S 397-400.
18. Hansotia JB, Agarwal V, Pathak AA and Saoji AM. Extended-spectrum β-lactometers mediated resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. Indian J Med Res 1997; 105: 158-161.
19. Karbasizaed V, Badami N and Emtiazi G. Antimicrobial, heavy metal resistance and plasmid profile of coliforms isolated from Nosocomial infections in a hospital in Isfahan, Iran. Aferican J Biotech 2003; 2: 379-383.
20. Kucukates E and Kocazeybe K. High resistance rate against 15 different antibiotics in aerobic gram-negative bacteria isolates of cardiology intensive care unit patients. Indian J Med Microb 2002; 20: 208-210.
21. Li J, Ma Y, Wang Z and Yu X. Klebsiella pneumoniae: epidemiology and análisis of risk factors for infections caused by resistant strains. Chin Med J 2002; 115: 1158-1162.
22. Subha A, Ananathan S and alavandi SV. Extended-spectrum β-lactamase production and multi resistance Klebsiella species isolated from children unde five intestinal and extra intestinal infections. Indian J Med Res 2001; 113: 181-185.
23. Jacoby GA and Sultan I. Properties of plasmids responsible for production of extended-spectrum β-lactamases. Antimicrob Agents Chemoth 1991; 35: 164-169.
24. Paterson DL, Ko WC, Gottberg AV, Mohaptra S, Casellas JM, Goossens H, McCormarck JG and Yu VL. International prospective study of Klebsiella pneumoniae Bacteremia: Implication of Extended-spectrum β-lactamase production in nosocomial infections. Annals 2004; 140: 26-32.
25. Meyer KS, Urban C, Eagan JA, Berger BJ and Rahal JJ. Nosocomial outbreak of Klebsiella resistant to late-generation cephalosporins. Ann Intern Med 1993; 119: 353-358.
26. Rupp ME, Fey PD. Extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae; consider for diagnosis, prevention and drug treatment. Drugs 2003; 63: 353-365.
27. Casellas JM, Tome G, Bantar C, et al. Argentinean collaborative multi-center study on the in vitro comparative activity of piperacillin- tazobactam against selected bacterial isolates recovered from hospitalized patients. Diagn Microbiol Infet Dis 2003; 47; 527-37.
28. Mathai D, Rhomberg PR, Biedenbach DJ and Jones RN, Indian Antimicrobial Resistance Study Group, Evaluation of in vitro activity of six broad- spectrum β-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories. Diagon Microbiol Infect Dis 2002; 44: 367-377.
29. Ananthan, SA and Alavandi SV. Extended-spectrum β-lactamase production and multi-drug resistance in Klebsiella species isolated from children under five with intestinal and extra intestinal infections. Indian J Med Res 2001; 113: 181-185.
30. Manchanda V and Singh NP. Occurrence of AmpC β-lactometers among gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother 2003; 51: 415-418.